Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Glioblastoma 5Astrocytoma 5Neuroectodermal Tumors, Primitive 3Neurocytoma 2Glioma 2Brain Neoplasms 2Oligodendroglioma 1Lymphoma, Non-Hodgkin 1Gliosarcoma 1Ganglioglioma 1Craniopharyngioma 1

Interventions

Temozolomide 6Cyclophosphamide 4antineoplaston AS 2-1 3antineoplaston A10 3Radiotherapy 3Filgrastim 3sargramostim 2aldesleukin 2Vincristine 2Thalidomide 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Irinotecan 2Donepezil 2Cisplatin 2Carmustine 2Bevacizumab 2veliparib 1trametinib 1temsirolimus 1surufatinib 1spartalizumab 1sonidegib 1ribociclib 1reolysin 1plerixafor 1ganitumab 1fosbretabulin 1entinostat 1dactolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors, Primitive × antineoplaston A10 × Clear all
NCT00003458 2022-03-07

Antineoplaston Therapy in Treating Children With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
34 enrolled 6 charts
CNSSarcoma

Astrocytoma, Craniopharyngioma, Glioblastoma, Oligodendroglioma, Neuroectodermal Tumors, Primitive, Ganglioglioma, Neurocytoma, Gliosarcoma

NCT00003460 2017-08-24

PNET

Burzynski Research Institute

Phase 2 Completed
13 enrolled 6 charts

Neuroectodermal Tumors, Primitive

NCT00003457 2017-08-22

Antineoplaston Therapy in Treating Patients With Brain Tumors

Burzynski Research Institute

Phase 2 Completed
40 enrolled 6 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neuroectodermal Tumors, Primitive, Neurocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡